BioCentury
ARTICLE | Company News

American Biogenetic, Abbott deal

November 19, 2001 8:00 AM UTC

ABT discontinued its licensing agreement for MABA's ABS-103 valproic acid analog to treat epilepsy and bipolar mania and prevent migraine. MABA said it is seeking another partner for the preclinical p...